BriaCell Therapeutics (BCTX) vs Lite Strategy (LITS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lite Strategy (LITS) has outperformed BriaCell Therapeutics (BCTX) over the past year, losing 48.2% versus a loss of 68.3%. Over five years, BCTX leads with a -95.1% price change compared with -97.8% for LITS. Lite Strategy is the larger company by market cap ($36.2 million vs $34.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BCTX | LITS |
|---|---|---|
| Share price | $3.94 | $1.19 |
| Market cap | $34.23M | $36.19M |
| 1-day change | -1.63% | -6.28% |
| YTD return | -43.74% | -3.79% |
| 1-year return | -68.33% | -48.16% |
| 5-year return | -95.12% | -97.82% |
| EPS (TTM) | $-0.92 | $-2.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.68 | $2.97 |
| 52-week low | $2.60 | $0.69 |
| Distance from 52-week high | -73.19% | -59.93% |
| Average volume | 280.62K | 448.62K |
| Shares outstanding | 8.70M | 30.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LITS has outperformed BCTX by 20.2 percentage points over the past year.
BCTX vs LITS FAQ
Which is bigger, BriaCell Therapeutics or Lite Strategy?
Lite Strategy (LITS) is larger, with a market capitalization of $36.19M compared with $34.23M for BriaCell Therapeutics (BCTX).
Which stock has performed better over the past year, BCTX or LITS?
LITS returned -48.16% over the past 12 months, compared with -68.33% for BCTX (price return, excluding dividends). Past performance does not predict future results.
Are BriaCell Therapeutics and Lite Strategy in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.